Hi [[ session.user.profile.firstName ]]

Forensic Science

  • Mobile molecules: Keeping on track
    Mobile molecules: Keeping on track
    Prof Hagan Bayley and Dr Yujia Qing, University of Oxford Recorded: Feb 26 2020 46 mins
    Join the University of Oxford’s Professor Hagan Bayley and Reaxys PhD Prize 2019 winner Dr. Yujia Qing on February 26 for an exclusive look at their contributions to chemical nanotechnology. Professor Bayley will open the webinar by sharing his success in transforming a pore-forming protein into a stochastic sensor and a protein nanoreactor. Then Dr. Qing will discuss her work with a remarkable nanomachine: the molecular hopper that can move directionally along a protein track. Dr. Qing will also share her experience of the 2019 Reaxys PhD Prize! Attendees can ask questions during a live Q&A at the end of the webinar.
  • Innovation at Cell Press: How can librarians make the most of resources
    Innovation at Cell Press: How can librarians make the most of resources
    Dr. Deborah Sweet, Vice President of Publishing, Cell Press Recorded: Feb 25 2020 58 mins
    Learn all about innovation, growth in the multi-disciplinary content and the expanding open access publishing strategy at Cell Press with Dr. Deborah Sweet, Senior Vice President of Publishing at Cell Press.

    You can expect to learn more about the community outreach programs at Cell Press like webinars, symposia, Cell Mentor, Sneak Peek, STAR Methods, STAR Protocols and much more which can help your researchers as well as institutes to grow faster and deliver a higher impact in the world.

    We promise to make the webinar engaging and to answer all your questions around Cell Press. At Cell Press, everything we do aims to drive research forward — whether it's working with authors, enhancing the peer review process, or developing innovations in publishing. We put science first, science that people talk about.

    Join Dr. Sweet in this engaging webinar and make sure to bring along your colleague and friends who may benefit from these helpful resources.
  • SANS TALK: How to Use OSINT for Cyber Threat Intelligence Investigations
    SANS TALK: How to Use OSINT for Cyber Threat Intelligence Investigations
    SANS expert Jake Williams and Authentic8’s Head of Special Services, Nick Espinoza Recorded: Feb 20 2020 7 mins
    Renowned SANS expert Jake Williams and Authentic8's Head of Special Services, Nick Espinoza, discuss today's use of OSINT for Cyber Threat Intelligence (CTI).

    Get answers to the following questions:

    - Does Counterintelligence (CI) depend on an organization's maturity level?
    - Can an organization be too small to have a CTI program?
    - Why is a framework for CI so challenging to build?
    - How is managed attribution like CI on steroids?
    - Is it more relevant to prioritize spending on CTI tools or processes?

    You'll also receive instructions on how to participate in the CTI 2020 Survey. Watch the talk and join in the discussion on the magnitude of OSINT in CTI.
  • Learn valuable tips for impactful submissions from a Lancet editor!
    Learn valuable tips for impactful submissions from a Lancet editor!
    John McConnell, Editor-in-Chief of The Lancet Infectious Diseases Recorded: Feb 20 2020 76 mins
    Hear John McConnell, Editor-in-Chief of The Lancet Infectious Diseases, discuss how to prepare a manuscript for submission to leading journals and answer author's most frequently asked questions about the submission process. Due to the high level of engagement and positive feedback received from research communities around the globe, we are now making the recording of this webinar available to you.

    You can expect to learn:
    • How to choose a journal for submission
    • What to include in each section of your manuscript
    • The editorial decision-making process
  • Applying behavioural interventions in chronic diseases
    Applying behavioural interventions in chronic diseases
    Cara Blair, Robert Poole, Ian Greenway, Pippa Colden, Complete HealthVizion, Dominic Tyer, pharmaphorum Recorded: Feb 6 2020 62 mins
    Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on patients’ lives and the provision of healthcare around the world.

    Tackling conditions such as diabetes, heart disease and stroke is of vital importance if patient outcomes are to be improved and healthcare costs lowered.

    To achieve this, and in doing so address clinical inertia, a combination of innovative communication strategies and behavioural science can provoke small changes that produce a meaningful difference in health outcomes.

    This pharmaphorum webinar, in association with Complete HealthVizion, will look at how to help chronic disease patients to live well for longer, by providing a clear understanding of healthcare professionals’ and patients’ behaviours and communication needs.

    Focus

    The webinar will take place on Thursday 6th February from 14:00-15:00 GMT/09:00-10:00 EST, when a world-class faculty representing a wide-range of disciplines, including social science, multichannel and medical affairs strategy, will discuss how behavioural change approaches can be used to avoid major health problems and the increasing costs associated with declining health.

    They will consider drivers of decision making in chronic disease management and look at why issues such as ‘behavioural complacency’ prevent progress and consider the lack of short-term benefits associated with many disease management approaches.

    All too often there is little urgency to act in patients at risk from chronic disease, despite a growing burden that increases their suffering and the time they spend in clinical practices with HCPs.

    This webinar will help change that, by looking at:

    •How to assess readiness to change among patients and HCPs
    •What strategic approaches work best in this setting
    •How to target the most important HCPs and convince them of the need for change
    •How to measure the effectiveness of behavioural change tactics
  • Informed patients: evolving healthcare, clinical trials and medical information
    Informed patients: evolving healthcare, clinical trials and medical information
    Andrew Schorr, Patient Power, Dominic Jack, Merck, Vale Nicoli-Carr, mdgroup, Dr Vidal Pérez, Cardiologist, Dom Tyer, pp Recorded: Feb 5 2020 62 mins
    Overview

    Patients are more informed than ever about their conditions and what is available for them to improve their quality of life.

    The healthcare sector is increasingly focused on understanding patient needs and engaging them in the clinical development and medical information process. Therefore, it is paramount to create patient-focused educational content using a range of communication channels and digital tools.

    However, do we take any time to think like a patient and, by doing so, understand their evolving needs and how this will affect the development of clinical trials and other healthcare educational initiatives?

    This pharmaphorum webinar, held in association with Plenum and mdgroup, takes place on Wednesday 5th February from 14:00-15:00 GMT and will look at the impact of patient involvement, from clinical programme design through to launch and post-launch activities.

    Focus

    • What should patient-led communication look like and who will provide it?
    • How to best meet patients’ needs during clinical trials
    • Which meeting formats and other channels are most relevant to reach the broadest and most appropriate audiences?
    • What role will each stakeholder play in the future?

    Register to find out more and be part of this exciting debate.
  • Reaxys PhD Prize 2020 - Tips and Tricks for Applicants
    Reaxys PhD Prize 2020 - Tips and Tricks for Applicants
    Dr Friedrich Kroll and Alica May - Reaxys PhD Prize team Recorded: Feb 5 2020 32 mins
    This webinar will provide interested applicants with an overview of the prestigious Reaxys PhD Prize competition. It will cover submission requirements, eligibility criteria, deadlines and walk researchers through the application platform. Be sure to tune in if you are a young chemist and are thinking of applying to the 10th anniversary of this global competition! There will be plenty of time for Q&A at the end.
  • A Risk Adaptive Approach to Data Protection
    A Risk Adaptive Approach to Data Protection
    Karlene Berger, Director Product Marketing Recorded: Jan 15 2020 9 mins
    One of the biggest challenges in Data Security is protecting critical data in a way that doesn’t frustrate users, overwhelm admins or mistake malicious action for normal employee behavior.

    Risk-adaptive protection dynamically applies monitoring and enforcement controls to protect data, based on the calculated behavioral risk level of users and the value of data accessed. Risk levels are driven up and down based on user behavior, with each person having a unique risk level.

    Learn more about how taking a risk-adaptive approach combined with behavioral analytics can enable your security to fluctuate based on the threat environment.
  • Learn how Lancet editors decide which papers to accept for publication
    Learn how Lancet editors decide which papers to accept for publication
    Heather Van Epps, Editor-in-Chief The Lancet Rheumatology Recorded: Dec 12 2019 70 mins
    Join Heather Van Epps, Editor-in-Chief of The Lancet Rheumatology, to learn about techniques and strategies for preparing your paper to submit to high-impact journals.

    Heather will share her experiences working with researchers and authors throughout the research publishing cycle. You will learn how to develop papers for submission to publications like the Lancet family of journals.

    Do not miss this engaging webinar―you are invited to join and ask any questions that you feel will benefit your research.

    Don't forget to download your manuscript checklist from the resources section.
  • Reaxys training webinar
    Reaxys training webinar
    Dr Marta da Pian Recorded: Dec 5 2019 40 mins
    This webinar will focus on Structure searches in Reaxys.

    - MarvinJS/ChemDraw editor (drawing tools and checkbox panel)
    - Reaction search (product/reagent/catalyst, Atom mapping, Reacting center)
    - Diving into the Result panel
  • EMEA: From Reactive to Proactive Data Protection
    EMEA: From Reactive to Proactive Data Protection
    Dr. Chris Boorman, Security Evangelist, Forcepoint & Mike Smart, Director Product Marketing, Forcepoint Recorded: Dec 4 2019 19 mins
    In today’s world, organisations typically audit data access and use rather than enforcing protection policies. As a result, security teams spend their energy investigating data incidents, identifying breaches and cleaning up after the incident. But with a greater focus on how organizations are protecting data and responding to regulations, can we move to a world where we actually stop data breaches from occurring but without impacting the productivity of the workforce?

    In this session, Security Evangelist Chris Boorman and Director of Product Marketing Mike Smart, analyse this challenge using the Data Protection Maturity Curve and map how organisations can move from the Data Swamp, through Visibility and Analysis to a state of Proactive Automation.

    How valuable is your data? Watch our video discussion and learn how you can move your organisation along the maturity curve.
  • The Science of Healthcare Congresses
    The Science of Healthcare Congresses
    Eva Thalmann, Janssen, Jean-Yves Douillard, ESMO, Katie Koziol and Andrew Moore, Ashfield Meetings & Events Recorded: Dec 3 2019 70 mins
    Research from Ashfield Meetings & Events clearly demonstrates that face-to-face meetings and events form a major part of continuing medical education (CME). National and international congresses have been identified as the primary event to attend by HCPs.

    But what makes congresses such a valuable education channel for time-restricted physicians? This pharmaphorum webinar, in association with Ashfield Meetings & Events, will dive into a unique study of HCP educational and behavioural preferences towards attendance at medical congresses.

    Ashfield Meetings & Events’ The Science of Healthcare Congresses study, involved over 200 HCPs, drawn from a range of therapy areas, from both Europe and the US to ask what really matters to them and share some intriguing insights.

    These encompassed how HCPs value this type of activity, how they apportion their time on-site and engage with the healthcare industry, and how they evaluate a congress once its doors have closed for another year.

    Join our expert panel on Tuesday 3rd December to find out more on:

    • Why physicians attend congresses
    • How to ensure medical education provides value to attendees
    • How pharma can enhance industry symposia

    In addition, our panel will also share the results of an ongoing association and multi-pharmaceutical company research project, designed to standardise and benchmark the evaluation process of all congress medical education activities.
  • How to apply global brand strategies to every customer interaction
    How to apply global brand strategies to every customer interaction
    Massimiliano Siciliano, Grunenthal, Kasper Jerlang, LEO Pharma, Alejandra Betancourt, Anthill Agency, Dom Tyer, pharmaphorum Recorded: Nov 28 2019 62 mins
    Pharmaceutical companies spend a huge amount of time and resources on creating valuable brand strategies, but when they come to life there’s often a disconnect.

    Strategy and execution can easily drift apart when tactics come to life, making it harder for them to drive business and deliver on the long-term action plans to engage with healthcare professionals.

    This is as true for eDetailing or closed-loop marketing initiatives as it is for multichannel marketing strategies that encompass the latest chatbot technology or innovative digital content platforms.

    To remedy this, those working in pharma on multichannel marketing, brand planning and digital need to apply the human factor to their global brand strategies to achieve the kind of tactics that deliver on strategic goals.

    Focus

    Join Anthill on Thursday 28th November from 13:00 GMT / 14:00 CET for a live expert panel discussion on multichannel marketing, brand planning and how to apply global brand strategies in pharma to every customer interaction for greater HCP reach and return-on-investment.

    In addition to looking at brand planning across pharma, common frustrations for the industry and whether or not brand planning is set up to deliver good multichannel marketing, the webinar will also cover:

    • The most common challenges in the brand planning process
    • How to build executional and strategic understanding across an entire brand plan
    • How to activate your existing channels and create the best channel mix for customers
    • How insight-based multichannel marketing can drive strategy and build new insights for the future

    The pharmaceutical industry has been making great progress in its digital transformation, but boundaries are there to be pushed if companies want to continue to innovate their marketing practices and processes.
  • APAC: Unified Data Protection for Hybrid IT- part 2
    APAC: Unified Data Protection for Hybrid IT- part 2
    Ankur Chadda, Senior Product Marketing Manager Recorded: Nov 28 2019 37 mins
    A deeper dive into the use cases & challenges businesses face

    Enterprises are facing new challenges when it comes to protecting regulated data and critical IP. In part two of the Unified Data Protection for a Hybrid IT World webinar series, we take a deeper dive into use cases around the challenges that businesses are facing today and how Forcepoint’s solutions meet your data protection needs.

    Understanding the location of all data, whether at-rest, in-use, and in motion across on-premises and the cloud is essential to keep data safe and secure. This enables companies to identify its riskiest users and behaviors. With Forcepoint, you can automate the identification, classification and protection of critical data.

    This webinar explores how companies should rethink data security. Addressing the challenges of protecting Critical Data & Intellectual property requires a new approach: a risk-adaptive, dynamic approach to data protection, including these three main components.

    - Analytics Driven Visibility – to gain oversight everywhere users work and collaborate
    - Risk-Adaptive Controls – to eliminate the complexity of policy enforcement
    - Intelligent & Dynamic Automation – building a better understanding of context and user intent
  • EMEA: Unified Data Protection for Hybrid IT - Part 2
    EMEA: Unified Data Protection for Hybrid IT - Part 2
    Ankur Chadda, Senior Product Marketing Manager Recorded: Nov 27 2019 37 mins
    A deeper dive into the use cases & challenges businesses face

    Enterprises are facing new challenges when it comes to protecting regulated data and critical IP. In part two of the Unified Data Protection for a Hybrid IT World webinar series, we take a deeper dive into use cases around the challenges that businesses are facing today and how Forcepoint’s solutions meet your data protection needs.

    Understanding the location of all data, whether at-rest, in-use, and in motion across on-premises and the cloud is essential to keep data safe and secure. This enables companies to identify its riskiest users and behaviors. With Forcepoint, you can automate the identification, classification and protection of critical data.

    This webinar explores how companies should rethink data security. Addressing the challenges of protecting Critical Data & Intellectual property requires a new approach: a risk-adaptive, dynamic approach to data protection, including these three main components.

    - Analytics Driven Visibility – to gain oversight everywhere users work and collaborate
    - Risk-Adaptive Controls – to eliminate the complexity of policy enforcement
    - Intelligent & Dynamic Automation – building a better understanding of context and user intent
  • EMEA: Unified Data Protection for Hybrid IT - Part 1
    EMEA: Unified Data Protection for Hybrid IT - Part 1
    Karlene Berger, Director of Product Marketing, Forcepoint Recorded: Nov 20 2019 20 mins
    A dynamic approach to protect data wherever it resides

    Enterprises are facing new challenges when it comes to protecting regulated data and critical IP: 90% of the World's data has been created in the last two years, whilst there is an increase in places where it is stored and by the number of people who have access.

    This webinar explores how companies should rethink data security, focusing on the following three principles:

    - Analytics driven visibility to give gain oversight everywhere users collaborate
    - Risk-adaptive controls to eliminate the complexity of policy enforcement
    - Intelligent and dynamic automation - building a better understanding of context and user intent and getting to action faster
  • Improving diversity and inclusion in research and publishing
    Improving diversity and inclusion in research and publishing
    Dr Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology Recorded: Nov 14 2019 72 mins
    Gender equity is not only a matter of justice and rights, it is crucial for producing the best research and providing the best care to patients. If the fields of science, medicine, and global health are to improve human lives, they must be representative of the societies they serve. The fight for gender equity is everyone’s responsibility: men and women, researchers, clinicians, funders, institutional leaders, and, yes, even medical journals.

    Join Dr Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, to learn about:
    • Why is gender equity important in research
    • What do statistics say about diversity and inclusion in publishing
    • What initiatives have been started at The Lancet to bridge the gap
  • From Reactive to Proactive Data Protection
    From Reactive to Proactive Data Protection
    Dr. Chris Boorman, Security Evangelist, Forcepoint & Mike Smart, Director Product Marketing, Forcepoint Recorded: Nov 13 2019 19 mins
    In today’s world, organizations typically audit data access and use rather than enforcing protection policies. As a result, security teams spend their energy investigating data incidents, identifying breaches and cleaning up after the incident. But with a greater focus on how organizations are protecting data and responding to regulations, can we move to a world where we actually stop data breaches from occurring but without impacting the productivity of the workforce?

    In this session, Security Evangelist Chris Boorman and Director of Product Marketing Mike Smart, analyze this challenge using the Data Protection Maturity Curve and map how organizations can move from the Data Swamp, through Visibility and Analysis to a state of Proactive Automation.

    How valuable is your data? Watch our video discussion and learn how you can move your organization along the maturity curve.
  • Viral Safety by Design for Cell and Gene Therapy Products
    Viral Safety by Design for Cell and Gene Therapy Products
    Mark Plavsic, Chief Technology Officer at Lysogene & Archie Lovatt, Life Sciences Biosafety Scientific Director at SGS Recorded: Nov 11 2019 67 mins
    Together with product efficacy, product safety is an essential characteristic of any medicinal product including cell and gene therapy (C&GT) biologics. Adventitious agents (viruses, bacteria, mycoplasma, prions, etc) pose constant risk to these biologics, and, as such they may impact directly product and patient safety. It is therefore of supreme importance to intentionally (by design) employ effective measures across the whole C&GT product manufacturing process to mitigate risk of adventitious agents. This presentation will review various interconnected steps throughout the manufacturing process, from the raw materials to the fill and finish, that would, in concert, help mitigate the risk while providing a high degree of product safety by design.
  • 爱思唯尔卓越科研在线讲座重播:在《柳叶刀》上发表论文——专为中国研究人员打造的中文在线讲座!
    爱思唯尔卓越科研在线讲座重播:在《柳叶刀》上发表论文——专为中国研究人员打造的中文在线讲座!
    Helena Wang Recorded: Nov 7 2019 60 mins
    与《柳叶刀》亚洲区执行主编王辉(Helena Wang)女士一起学习在高影响力期刊上发表论文的技巧和策略。王辉女士分享了她在整个研究论文发表周期中与研究人员和论文作者合作的经验,介绍如何撰写能够在优质出版物上发表的论文,以及广泛传播研究成果的机会。本次研讨会内容精彩纷呈,不容错过,能够让您的研究过程和研究影响再上新台阶。This webinar is in Mandarin (Chinese).
  • Pharmaceutical Forensics for Safe Manufacturing and Supply
    Pharmaceutical Forensics for Safe Manufacturing and Supply
    Ravi Kalyanaraman and Jeremy Peters of BMS and Robert Heintz of Thermo Fisher Scientific Recorded: Nov 6 2019 76 mins
    Why Use Raman Microscopy for Pharmaceutical Forensics?
    by Dr. Robert Heintz, Senior Applications Specialist at Thermo Fisher Scientific

    Raman microscopy is uniquely suited for providing essential information for pharmaceutical forensic applications. The use of visible lasers allows for analysis of very small samples with spatial resolutions down to a micron or better. Materials can be analyzed in glass containers and through transparent packaging. Mapping and imaging provides information on the spatial distribution of components as well as particle sizes and shapes. Confocal operation allows for probing inside transparent materials and analyze different layers or inclusions without the need to cut or cross-section the sample. Raman microscopy is non-destructive and preserves the sample for further analysis. Raman spectra can be used not only for the conformation of expected components but also the identification of unknown contaminants or impurities. Spectral features are very sensitive to molecular structure and can be used to distinguish polymorphs and other very chemically similar materials.

    Followed by Pharmaceutical Forensics for Safe Manufacturing and Supply
    by Ravi Kalyanaraman, Director at BMS

    Pharmaceutical Investigations and Technology (PIT) is a group within Global Analytical Technology (GAT) department in the commercial Quality organization within Bristol-Myers Squibb. The PIT group has been a key part in BMS for 30 + years in providing analytical support for commercial manufacturing and in pharmaceutical forensics. This include particulate and foreign matter characterization in pharmaceutical products and screening counterfeit drugs. Several analytical tools and techniques are used by PIT to support the pharmaceutical forensics.This talk will feature all the analytical techniques used by PIT and how the results are used in resolving manufacturing issues and to protect patients from counterfeit drugs.
  • Cost & Management of Oncology Combination Regimens
    Cost & Management of Oncology Combination Regimens
    Marcia Palmer, Allen W. Becker, Anthony Chiefari, Howard Deutsch, Nicolle Hamilton, ZS Associates Recorded: Oct 30 2019 88 mins
    Overview
    Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator drugs (versus older, generic chemotherapies).

    Payers are in a difficult spot regarding the cost and management of these regimens. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying treatment. Pathways have not held up to their promise for containing cost.

    Personalized medicine approaches such as biomarkers serve an important role in targeting therapy to the most appropriate patients, thereby reigning in cost. However, there are limitations in the breadth and utility of these tools. For example, PD-1/PDL-1 drugs have shown conflicting outcomes associated with receptor expression – and these drugs are the backbone for many combo regimen programs in clinical development.

    Environment/perception shifts, new approaches to management, indication-based pricing or other novel pricing approaches, and innovative payment models may hold promise for controlling cost in this new era of combination therapy.

    Focus
    Join ZS Associates for a live expert payer panel discussion on the challenges and potential solutions for managing the cost of combo oncology regimens. Topics will include:

    •Perspectives on oncology drug management and combination regimen pricing today
    •Potential payer-driven and pharma-driven solutions to price and cost management for oncology combo regimens
    •What oncology manufacturers should consider in engaging payers in the future

    The live payer webinar, co-moderated by Nicolle Hamilton, ZS Associates and Dominic Tyer, pharmaphorum, will take place on Wednesday, October 30 2019 from 14:00-15:15 GMT/10:00-11:15 ET.
  • Unified Data Protection for Hybrid IT - Executive Summary
    Unified Data Protection for Hybrid IT - Executive Summary
    Karlene Berger, Director of Product Marketing, Forcepoint Recorded: Oct 30 2019 20 mins
    "Enterprises are facing new challenges when it comes to protecting regulated data and critical IP.
    This webinar explores how companies should rethink data security. Addressing the challenges of protecting Critical Data & Intellectual property requires a new approach: a risk-adaptive, dynamic approach to data protection."
  • Showcasing your research: Present the full picture of your research achievements
    Showcasing your research: Present the full picture of your research achievements
    Heather Williams Recorded: Oct 29 2019 40 mins
    This 45 minute webinar will discuss how Elsevier supports researchers by providing tools to effectively showcase their research profile and increase their visibility, a skill that is vital in the research world.
  • Design of remote luminescent thermometers for bio-imaging
    Design of remote luminescent thermometers for bio-imaging
    Dr. Markus Suta, Utrecht University Recorded: Oct 24 2019 54 mins
    Join Reaxys Prize Club member Dr. Markus Suta for fascinating insights into luminescence thermometry. In this webinar, he describes the development and validation of remote lanthanide-based luminescent thermometers with applications in bio-imaging. Discover why a combination of in silico modelling and wet-lab experiments were essential to the success of the project. Dr. Suta also talks about the importance of efficient literature research to his work.

    In addition, Dr Marta da Pian will give an overview on tips and tricks for using Reaxys.

    We hope you can join us!
  • From Reactive to Proactive Data Protection
    From Reactive to Proactive Data Protection
    Dr. Chris Boorman, Security Evangelist, Forcepoint & Mike Smart, Director Product Marketing, Forcepoint Mar 4 2020 4:00 pm UTC 19 mins
    In today’s world, organizations typically audit data access and use rather than enforcing protection policies. As a result, security teams spend their energy investigating data incidents, identifying breaches and cleaning up after the incident. But with a greater focus on how organizations are protecting data and responding to regulations, can we move to a world where we actually stop data breaches from occurring but without impacting the productivity of the workforce?

    In this session, Security Evangelist Chris Boorman and Director of Product Marketing Mike Smart, analyze this challenge using the Data Protection Maturity Curve and map how organizations can move from the Data Swamp, through Visibility and Analysis to a state of Proactive Automation.

    How valuable is your data? Watch our video discussion and learn how you can move your organization along the maturity curve.
  • Must Know Tips for Publishing in Premium Journals
    Must Know Tips for Publishing in Premium Journals
    Dr. Philip Earis, Editor-in-Chief, Joule, Cell Press Mar 5 2020 9:00 am UTC 60 mins
    Join Dr. Philip Earis, Editor-in-Chief of Joule (Cell Press journal) for an engaging webinar to learn about techniques and strategies for authoring in high impact journals. Dr. Earis will present his experience working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications, and the opportunity to broadly disseminate findings. Dr. Earis will talk to you about growth of Cell Press journals in the physical sciences field, which includes launch of many new titles such as Chem, Joule, Matter, and One Earth. He’ll also outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press. You won’t want to miss this informative webinar and how it can benefit your research process and impact. Please extend this invite to colleagues who may also find it of interest.

    More about Dr. Philip Earis:
    Philip is a graduate of Cambridge University in England and brings over 10 years of experience in publishing impactful energy research to Joule. He came to Cell Press after 3 years of living in India, where he founded and ran Project Light, an organization bringing solar power to marginalized off-grid communities in India. In this role, he worked closely with Indian and international scientists to develop and install appropriate solar energy technology.
  • How ‘thinking modular’ might ease digital content overload in pharma
    How ‘thinking modular’ might ease digital content overload in pharma
    Morten Kruse Sørensen, Novo Nordisk, Florent Edouard, Grünenthal Group, Huw Jenkins, Veeva, Kasper Jerlang, LEO Pharma Mar 17 2020 1:00 pm UTC 75 mins
    Overview
    In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based on their target product profile alone.

    Instead, the key factor now is often the quality of customer engagement, which more and more healthcare professionals (HCPs) appear to value.

    It’s enabled by a multichannel marketing (MCM) approach, but traditional MCM strategies require a much higher level of content than pharma is used to producing and approving – the answer to this is a modular approach.

    Such modular content allows pharma to meet HCPs’ information demands by leveraging content assets across multiple channels and in many different combinations, at the same time providing superior targeting and tracking.

    This pharmaphorum webinar, held in association with Anthill, will take place on Tuesday 17 March from 13:00 to 14:00 (GMT)/14:00 to 15:00 (CET) and will look at how the use of modular content in pharma can ease some digital worries.

    Focus
    Our expert panel will discuss:

    •The most common challenges in the digital content creation process
    •Aligning content creation tactics with the multichannel marketing strategy
    •How to activate your existing content to maximise existing resource for the greatest HCP reach
    •Making the customer experience a key differentiator

    Our Panel
    •Morten Kruse Sørensen, Global Director Multichannel Excellence and Operations, Novo Nordisk
    •Florent Edouard, SVP, Global Head of Commercial Excellence, Grünenthal Group
    •Huw Jenkins, Director, DAM Strategy, Veeva
    •Kasper Jerlang, Head of Global Digital Marketing and Engagement, LEO Pharma
    •Tor Kristensen, CTO, Anthill Agency
    •Dominic Tyer, Creative and Editorial Director, pharmaphorum [moderator]
  • Reaxys training webinar - Medicinal Chemistry
    Reaxys training webinar - Medicinal Chemistry
    Dr Marta da Pian Mar 17 2020 2:00 pm UTC 45 mins
    This Reaxys training webinar will focus on Medicinal Chemistry.

    The following topics will be addressed in this session:

    1. Query builder (Target search)
    2. Diving into the Result panel
    3. Heatmap (Structure Activity Relationship)
  • Essential tips for publishing in high-impact journals
    Essential tips for publishing in high-impact journals
    Dr. Rose Zhu, Associate Scientific Editor, Joule Mar 18 2020 1:00 pm UTC 75 mins
    Discover the best techniques and strategies for authoring in high impact journals with Dr. Rose Zhu, Associate Scientific Editor at Joule (Cell Press journal). You can expect to learn:
    •Techniques and strategies for improving the scientific writing process including tips on writing a better introduction, creating an effective abstract and analysing the results in your research paper
    •Tactics on developing papers for premium publications
    •Exploring the opportunities to broadly disseminate findings
    •Discover the Cell Press physical science portfolio of journals including newly launched titles such as Chem, Joule, Matter & One Earth

    Dr. Zhu will also outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press.

    Sign up for this interesting free webinar and learn best tips & tricks to benefit your research process and increase your research impact.

    Bring along a friend or colleague who might be instrumental in improving your research paper.

    Here’s a quick introduction about Dr. Rose Zhu:
    Dr. Rose Zhu joined Joule as Associate Scientific Editor in 2017 and is based in the Shanghai office. Since 2017, Dr. Zhu has given over 100 talks on scientific writing and publishing techniques with Joule and other Cell Press physical science journals. Dr. Zhu completed her Ph.D. from Nanyang Technological University (NTU, Singapore) after completing the BSc degree at Sichuan University (China). Dr. Zhu has published 10+ papers in the physical sciences field covering wide array of topics like Nano energy, material horizon and much more.
  • Expert Advice: How to publish in ACC Journals
    Expert Advice: How to publish in ACC Journals
    Valentin Fuster, M.D., Ph.D. Mar 26 2020 9:00 am UTC 75 mins
    Hear Valentin Fuster, MD, Ph.D., Editor-in-Chief of the Journal of the American College of Cardiology (JACC) to learn about techniques and strategies for publishing in high-impact journals. Dr. Fuster presents information on publishing in ACC Journals, which include JACC, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Heart Failure, JACC: Clinical Electrophysiology and JACC: Basic to Translational Science. Dr. Fuster presents his expertise in working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications, and the opportunity to broadly disseminate findings. Due to the high engagement, we received in the original webinar we're making the recording of the webinar available to you on popular demand. You won’t want to miss this engaging webinar and how it can benefit your research process and impact.